Literature DB >> 15464683

Effects of ventricular rate regularization pacing on quality of life and symptoms in patients with atrial fibrillation (Atrial fibrillation symptoms mediated by pacing to mean rates [AF SYMPTOMS study]).

Hung-Fat Tse1, David Newman, Kenneth A Ellenbogen, Trina Buhr, Toby Markowitz, Chu-Pak Lau.   

Abstract

The aim of this study was to investigate the effect of the Ventricular Response Pacing (VRP) algorithm, which regularizes ventricular rate during atrial fibrillation (AF), on symptoms, quality of life, and functional capacity. VRP regularizes the ventricular rate during AF without increasing the mean ventricular rate, thereby reducing the severity of AF-related symptoms in patients with persistent AF. However, VRP did not improve general quality of life (Medical Outcomes Study 36-item Short-Form General Health Survey), the performance of routine activities (Duke Activity Status Index), or functional capacity (hall walk) in patients with AF.

Entities:  

Mesh：

Year:  2004        PMID： 15464683     DOI： 10.1016/j.amjcard.2004.06.034

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

2.  Quality of life among people with atrial fibrillation with and without diabetes: a comparison study.

Authors:  Angela Hall; Andrew Robert John Mitchell; Lisa Ashmore; Carol Holland
Journal:  Br J Cardiol       Date:  2021-10-13

Review 3.  Controversies in pacing: indications and programming.

Authors:  Anne M Gillis; Rik Willems
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

4.  Adverse effects of continuous ventricular pacing in patients with slower atrial fibrillation and normal left ventricular systolic function.

Authors:  John A Chiladakis; Nikolaos Koutsogiannis; Andreas Kalogeropoulos; Panagiotis Arvanitis; Dimitrios Alexopoulos
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-04       Impact factor: 1.468

5.  Electrophysiological characteristics associated with symptoms in pacemaker patients with paroxysmal atrial fibrillation.

Authors:  John Silberbauer; Rick A Veasey; Elizabeth Cheek; Nadeem Maddekar; Neil Sulke
Journal:  J Interv Card Electrophysiol       Date:  2009-07-28       Impact factor: 1.900

6.  Ventricular Rate Stabilization In Patients With Permanent Atrial Fibrillation And Single-Chamber Ventricular Pacemaker: RARE-PEARL Study.

Authors:  Eraldo Occhetta; Gianfranco Mazzocca; Carla Svetlich; Pietro Scipione; Alessandro Fabiani; Massimo Giammaria; Serafino Orazi; Giorgio Corbucci
Journal:  J Atr Fibrillation       Date:  2014-04-30

7.  Pacemaker prevention therapy in drug-refractory paroxysmal atrial fibrillation: reliability of diagnostics and effectiveness of prevention pacing therapy in Vitatron selection device.

Authors:  Paolo Terranova; Paolo Valli; Peppino Terranova; Simonetta Dell'Orto; Enrico Maria Greco
Journal:  Indian Pacing Electrophysiol J       Date:  2006-04-01

8.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation.

Authors:  Maurizio Gasparini; Angelo Auricchio; Marco Metra; François Regoli; Cecilia Fantoni; Barbara Lamp; Antonio Curnis; Juergen Vogt; Catherine Klersy
Journal:  Eur Heart J       Date:  2008-04-04       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.